Antibody reaction to immunization with recombinant hepatitis B vaccine in undergraduates

Yin HUANG,Zhi CHEN,Ling-fei CAI

2001-01-01

Abstract:Objective To evaluate the safety and immunogenicity of recombinant hepatitis B（HB）vaccine to undergraduates and lay a basis for formulaing an immunization strategy．Method Yeast derived recombinant HB vaccine（YDV）was given at 0，1 and 2 months to 165 undergraduates whose hepatitis B virus markers （HBVM） were negative before vaccination，and then to detect the titer of antibody against hepatitis B surface antigen（anti-HBs）with radioimmunoassay（RIA）．Result No severe adverse reaction was found in all vaccinee．Positive seroconvertion rate was 81．41 percent two months after three-dose schedule，but most subjects were lowresponders，whose mean geometric titer（GMT）were at 10-99IU／L．Only 1．92 percent of the subjects reached the level that is higher than 100IU／L．7 of 12 non-responders to primary HB vaccination showed response to HB antigen after our 3-dose schedule．Conclusion Safety and immunogenicity of recombinant HB vaccine is good for undergraduates，but the levels of anti-HBs are too low．This response seems not to be influenced by sex．Non-responders to primary HB Vaccine should be given it again in order to reach sufficient anti-HBs levels．